ARWR
Arrowhead Pharmaceuticals Inc
67.00$
-6.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 48.3% | 11.1% | 7.7% | 8.4% | 67.6% | 3.8% | – | 38.1% | 109.0% | 1,235.7% | 974.8% | 1,139.8% | 240.3% | 798.7% | 90.5% | 1,190.8% | 1,093.2% | 2,176.2% | 21,461.8% | 52,075.1% | 202.9% | 417.4% | – | – | – | 4.3% | 5.2% | 523.7% | 2.9% | |
| 51.7% | 88.9% | 92.3% | 91.6% | 32.4% | 96.2% | – | 61.9% | -9.0% | -1,135.7% | -874.8% | -1,039.8% | -139.9% | -698.7% | 9.5% | -1,090.8% | -993.2% | -2,076.2% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 94.8% | -423.7% | 100.0% | |
| – | – | – | – | – | – | – | 404.1% | 642.2% | 1,441.2% | 905.3% | 637.6% | 165.2% | 138.3% | 1,106.8% | 3,670.8% | 2,999.2% | 13,221.7% | 12,373.7% | 26,181.8% | 147.3% | 299.2% | 45.4% | 140.4% | 149.2% | 122.2% | 142.2% | 13,776.9% | 73.2% | |
| 14.7% | 66.2% | 151.9% | 530.7% | 1,173.5% | 6,346.0% | – | 466.0% | 453.2% | 845,428.6% | 363,340.4% | 525,500.8% | 373.5% | 1,289.3% | 2,222.2% | 9,597.0% | 4,028.3% | 13,954.0% | 9,088.5% | 14,902.1% | 55.7% | 118.4% | 15.7% | 59.4% | 58.6% | 51.2% | 37.8% | 2,726.6% | 14.7% | |
| 258.8% | 129.2% | 244.2% | 530.7% | 1,173.5% | 62,594.6% | – | 1,472.4% | 1,576.0% | 2,304.2% | 1,472.1% | 1,394.7% | 324.1% | 720.8% | 3,329.0% | 13,267.8% | 7,027.5% | 27,126.0% | 21,462.2% | 52,075.5% | 202.9% | 417.4% | 61.1% | 199.1% | 207.8% | 173.4% | 180.0% | 16,503.4% | 88.1% | |
| -207.1% | -40.2% | -151.9% | -439.1% | -1,141.2% | -62,498.4% | – | -1,370.7% | -1,624.0% | -3,439.9% | -3,141.4% | -2,685.9% | -520.5% | -1,419.5% | -3,319.5% | -14,358.6% | -8,471.3% | -30,443.6% | -25,124.1% | -51,627.1% | -117.8% | -346.5% | 36.3% | -105.9% | -107.8% | -73.4% | -85.2% | -16,927.1% | 11.9% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 4.0% | 7,744.8% | 29,219.4% | 24,487.5% | 33.7% | 368,853.1% | 190,879.1% | 167,870.2% | 1,321.7% | 6,495.5% | 4,122.0% | 10,444.7% | 4.4% | 2.1% | 7.6% | 911.1% | 10.8% | |
| -1,115.7% | -273.3% | -995.9% | -552.9% | -1,995.5% | -10,865.3% | – | -1,271.6% | -1,183.0% | -3,681.9% | -3,141.4% | -2,694.7% | -509.8% | -1,183.1% | -2,966.5% | -15,054.1% | -10,922.1% | -33,554.3% | -24,067.7% | -51,613.1% | -109.5% | -337.3% | 40.4% | -96.1% | -101.9% | -71.0% | -85.8% | -17,247.5% | 6.2% | |
| 908.6% | 15.4% | -1,754.7% | 113.8% | 854.3% | -51,633.1% | – | 0.4% | -463.5% | -376.8% | -663.7% | -616.0% | 1.4% | -523.7% | -2,318.0% | -138.5% | 2,143.9% | 3.0% | 0.6% | 1.5% | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% | 1.6% | 1.2% | -77.9% | 2.6% | |
| -1,115.7% | -273.3% | 1,602.8% | -552.9% | -1,995.5% | -10,865.3% | – | -1,287.9% | -1,160.5% | -3,190.4% | -2,477.7% | -2,078.7% | -513.8% | -931.2% | -1,056.6% | -14,383.6% | -10,729.2% | -33,503.0% | -24,068.3% | -51,614.6% | -109.5% | -337.3% | 40.3% | -96.1% | -101.9% | -72.6% | -85.3% | -16,882.4% | -0.2% | |
| -71.6% | -25.0% | -130.0% | -408.4% | -1,103.3% | -62,097.8% | – | -1,332.7% | -1,515.0% | -3,291.0% | -3,058.3% | -2,598.9% | -494.0% | -1,585.7% | -3,229.0% | -13,167.8% | -7,417.3% | -28,433.3% | -24,512.5% | -48,272.9% | -102.9% | -317.4% | 38.9% | -99.1% | -95.9% | -69.1% | -73.0% | -15,812.8% | 19.9% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.